利用真实世界数据源识别成人皮肌炎患者
本研究基于观察性医疗结果合作项目通用数据模型,在11个独立电子健康记录或索赔数据库中开发并评估成人皮肌炎病例识别算法,共覆盖超过8亿患者。通过人工病历审查及开源工具评估,发现一个发病率算法和一个患病率算法表现良好,灵敏度分别为42%和49%,阳性预测值分别为83%和84%。
要点
- 在11个数据库中评估8种皮肌炎病例识别算法,部分数据库间灵敏度和阳性预测值差异超过30%。
- 发病率算法灵敏度42%、阳性预测值83%;患病率算法灵敏度49%、阳性预测值84%。
- CohortDiagnostics生成的按年龄十分位和性别分层的发病率与既往流行病学数据一致。
核心结论
- 研究开发并验证了多个皮肌炎病例识别算法,通过多种评估方法证明其准确性,可支持更具普遍性和可重复性的真实世界数据研究,并可应用于其他风湿性疾病。
研究设计与样本
- 研究在11个独立电子健康记录或索赔数据库中开发病例识别算法,总计覆盖超过8亿患者,使用观察性医疗结果合作项目通用数据模型。
- 算法性能通过人工病历审查和观察性健康数据科学与信息学开源工具(CohortDiagnostics和PheValuator)评估,量化发病率及灵敏度、阳性预测值等指标。
主要发现
- 共评估8种皮肌炎病例识别算法,不同数据库间性能差异显著,部分数据库间灵敏度和阳性预测值差异超过30%。
- 识别出一个发病率算法灵敏度42%、阳性预测值83%,一个患病率算法灵敏度49%、阳性预测值84%。
- PheValuator量化了各数据库内算法性能,允许直接比较不同标准;CohortDiagnostics生成的按年龄十分位和性别分层的发病率与既往流行病学数据一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Studying rare diseases like dermatomyositis (DM) in single-center cohorts is challenging due to small sample sizes and limited generalizability. This study develops and evaluates case identification algorithms for DM to enable coordinated analysis across multiple data sources. METHODS: Case identification algorithms were developed to identify adult patients with DM within 11 independent electronic health record or claims databases, totaling over 800 million patients, using the Observational Medical Outcomes Partnership Common Data Model. Algorithm performance was assessed through manual chart review and using Observational Health Data Sciences and Informatics open-source tools (CohortDiagnostics and PheValuator), which quantify incidence rates and performance metrics such as sensitivity and positive predictive value (PPV). RESULTS: Eight DM case identification algorithms were evaluated across 11 databases, revealing significant variability in performance, with sensitivity and PPV differing by more than 30% between some databases. Overall, we identified one incidence algorithm and one prevalence algorithm with good performance, demonstrated by sensitivity rates of 42% and 49% and PPV values of 83% and 84%, respectively. PheValuator quantified algorithm performance within each database, allowing for direct comparison of different criteria. Additionally, CohortDiagnostics generated incidence rates stratified by age decile and sex, aligning with previous epidemiologic data. CONCLUSION: We developed and validated multiple DM case identification algorithms across diverse databases, demonstrating their accuracy through multiple evaluation methods. This approach enables more generalizable, reproducible research using real-world data and can be applied to other rheumatic diseases.
引用
- Martin B, Kelly W, Morgan-Cooper H, et al. Identification of Adult Patients With Dermatomyositis Using Real-World Data Sources. Arthritis Care Res (Hoboken). 2025. PMID: 40790972. doi:10.1002/acr.25625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。